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external elastic membrane >1.05.
Results: All TOI showed TIMI thrombus grade 5; however, grade 1 was most frequent
in POI (Gr 0, n=5; Gr 1, n=17; Gr 2, n=12; Gr 3, n=9; Gr 4, n=2; and Gr 5, n=0). Vessel
size, lesion length, plaque burden, minimal lumen area (MLA), and remodeling index
were similar in TOI vs POI (Table). Plaque rupture was present in 48 pts: 27 TOI and
21 POI (p=0.3). Ruptured plaque cavity size was similar (0.81±0.78mm2 in TOI vs
0.93±0.81mm2 in POI, p=0.7). The incidence of VH-TCFAs tended to be higher in
TOIs [51% (34/67)] vs POI [27%(12/45), p=0.12]; %dense calcium within the culprit
lesions was larger in TOI vs POI (p=0.04); and peak troponin I was higher in TOI than
POI (366±218 mg/dl vs 156±260 mg/dl, p=0.012).
Conclusion: Totally-occluded IRAs in STEMI pts are associated with more culprit
lesion calcium and VH-TCFA morphology and greater myonecrosis indicating a higher
risk profile.
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Background: Reduced blood pressure (BP) decreased the cardiovascular events as
well as coronary plaque in patients with hypertension. An inverse relationship between
diastolic pressure and adverse cardiac ischemic events has been observed in numerous
studies. However, the association between BP and coronary plaque regression remains
unclear. We hypothesized that BP reduction with CCB could be correlated with
coronary plaque of hypertensive patients after percutaneous coronary intervention as
post hoc analysis from ALPS-J.
Methods: ALPS-J was designed to evaluate the impact of CCB therapy on plaque
volume in hypertensive patient. Subjects were randomly assigned to receive 16mg/day
of azelnidipine or 5mg/day of amlodipine administered for 48 weeks. Changes in
atheroma burden during 10 months monitored by intravascular ultrasound were studied.
115 patients were completely assessed at baseline and 10-months IVUS data. The
percentage change in plaque volume showed a significant regression of -4.67 and -
4.85% in azelnidipine and amlodipine, respectively. In this sub-analysis, the
relationship between BP and coronary plaque volume was examined. Patients were
divided according to the four quantiles of level of systolic and diastolic BP, and
coronary plaque volume were assigned to 4 groups.
Results: There is no relationship between systolic or diastolic BP and plaque volume.
There was a 4% increase in the plaque volume when the diastolic BP was <70 mm Hg
compared with >70 mm Hg (5% decrease). A J shaped curve association existed
between BP and plaque volume, with lowest plaque regression in the BP range of
approximately 70 mm Hg diastolic.
Conclusion: This is the first study to demonstrate a J-shaped curve association existed
between BP and coronary plaque regression, with lowest coronary plaque volume in
the BP range of approximately 70mm Hg diastolic, which suggests that too low of a
pressure (especially less than70 mm Hg) may be dangerous.
TCT-642
The Impact of Endothelial Wall Shear Stress on Vulnerable Plaque Growth
Wang-Soo Lee1, Sang-Wook Kim1, Young-Mi Jo1, Seung-Wook Kim2, Keung-Chul
Rho2, Seong-Wook Cho2, Hong-Sun Ryu2
1Chung-Ang University Hospital, Seoul, Republic of Korea; 2Mechanical
Engineering, Chung-Ang University, Seoul, Republic of Korea
Background: Plaque composition and plaque growth are affected by multiple factors.
Among them, the role of endothelial wall shear stress(EWSS), however, on vulnerable
plaque growth is not well studied.
Methods: We evaluated coronary CT angiography and virtual histology intravascular
ultrasound(VH-IVUS) image data on left anterior descending artery(LAD) from six
patients with thin-cap fibroatheroma(TCFA) and 6 patients with non-TCFA. We
performed volumetric plaque analysis and investigated circumferential 360 degree of
EWSS in vessel wall by computational fluid dynamics.
Results: Pt’s characteristics are as follows: mean age 60.0±8.7 yrs, male 83%, diabetes
17%, unstable angina 92%. There were no significant differences between 2 groups in
vessel area, lumen area, plaque burden, and remodeling index. VH-IVUS showed that
absolute area of fibrofatty component was significant smaller, but absolute area and
relative amount of necrotic core(NC) components were significant larger in TCFA
group than non-TCFA group. Relative amount of NC increased as average
EWSS(r=0.752, p=0.008) and velocity increased(r=0.829, p=0.041) in MLA site.
Average EWSS, oscillatory shear index, and velocity values of proximal reference site,
minimal lumen area site, and distal reference site were not different between 2 groups.
Maximal EWSS, however, was significantly greater in TCFA group than non-TCFA
group(p=0.044)(Table).
Conclusion: EWSS may have influence on plaque growth, especially NC component.
Furthermore, high EWSS potentially contributes to plaque destabilization in advanced
plaques.
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Background: Coronary Artery Disease continues to be a widespread and growing
problem worldwide. Performing PCI on calcified lesions can lead to MACE rates as
high as 24% at 30 days, stent malapposition and a number of procedural issues such
as perforation. The Orbit I trial evaluated the safety and performance of the
Diamondback 360 System (OAS) (Cardiovascular Systems, Inc., St. Paul, MN) for the
treatment of de novo calcified coronary lesions.
Methods: The Orbit I study was a prospective, non randomized trial conducted at two
centers in India from May 2008 to July 2008. 50 non-consecutive patients with a de
novo, coronary lesion with stenosis ≥50% and ≤100% and at least one quadrant of
calcification via IVUS, were treated with the OAS prior to stent placement. The
endpoints were safety as measured by MACE rates, TLR, procedural success and
device performance at 6 months.
Results: Of the 50 patients, 90% were male and the average age was 57.4 years. The
ACC/AHA Lesion Class was: Type A 6.0%; Type B1 50.0%; Type B2 44.0%. The
lesion length was 13.4 mm, and the number of devices used per patient was 1.3. The
percent diameter stenosis was 85.6% pre OAS; 40.0% post-OAS. Procedural success
was 94% of patients achieving ≤20% residual stenosis post stent. Device success was
98%, with no device failures. The overall MACE rate was 4% in-hospital (2 non Q-
wave MI); 6% at 30 days (1 additional non Q-wave MI leading to TLR); 8% at 6
months (1 cardiac death). The angiographic complication rate was measured acutely
and resulted in 7 subjects with one event each (4 minor dissections; 1 major dissection;
2 perforations).
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